Cumberland Pharmaceuticals (CPIX) EBIT Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -150.77% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | -10.00% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -0.93% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -9.25% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -97.30% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 4.05% |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 12.73% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.48 Mn | 112.62 Mn | - | -1.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.31% |
| Mar 31, 2026 | -342.22% |
| Dec 31, 2025 | 25.56% |
| Sep 30, 2025 | -15.98% |
| Jun 30, 2025 | 27.20% |
| Mar 31, 2025 | 169.12% |
| Dec 31, 2024 | 70.19% |
| Sep 30, 2024 | 9.22% |
| Jun 30, 2024 | -4,591.40% |
| Mar 31, 2024 | -22.04% |
| Dec 31, 2023 | -171.28% |
| Sep 30, 2023 | -546.81% |
| Jun 30, 2023 | 101.24% |
| Mar 31, 2023 | -18.55% |
| Dec 31, 2022 | 47.68% |
| Sep 30, 2022 | 81.54% |
| Jun 30, 2022 | -28.61% |
| Mar 31, 2022 | -298.40% |
| Dec 31, 2021 | -149.38% |
| Sep 30, 2021 | -29.35% |